0000950170-24-070603.txt : 20240607 0000950170-24-070603.hdr.sgml : 20240607 20240607160515 ACCESSION NUMBER: 0000950170-24-070603 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240606 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 241029277 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 8-K 1 sana-20240606.htm 8-K 8-K
0001770121false00017701212024-06-062024-06-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 6, 2024

 

SANA BIOTECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

Delaware

 

001-39941

 

83-1381173

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

 

(IRS Employer

Identification Number)

188 East Blaine Street, Suite 400

Seattle, Washington 98102

(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code: (206) 701-7914

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

SANA

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

Sana Biotechnology, Inc. (the “Company”) held its 2024 annual meeting of stockholders (the “Annual Meeting”) on June 6, 2024. The final results for each of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are set forth below. These proposals are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2024.

 

Proposal 1: The Company’s stockholders elected all the nominees to serve as Class III directors of the Company’s Board of Directors, each to serve for a three-year term expiring at the Company’s 2027 annual meeting of stockholders or until his or her respective successor is duly elected and qualified, by the votes set forth in the table below:

 

Nominees

For

Withheld

Broker Non-Votes

Joshua H. Bilenker, M.D.

148,997,261

16,148,638

13,427,015

Richard Mulligan, Ph.D.

149,561,266

14,901,700

14,109,948

Mary Agnes (Maggie) Wilderotter

144,161,860

20,256,138

14,154,916

 

Proposal 2: The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 by the votes set forth in the table below:

 

For

Against

Abstain

178,501,678

 

65,444

 

5,792

 

1

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Sana Biotechnology, Inc.

Date: June 7, 2024

By:

/s/ Bernard J. Cassidy

Bernard J. Cassidy

Executive Vice President and General Counsel

 

2

 EX-101.SCH 2 sana-20240606.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Pre Commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, State or Province Entity Address, State or Province Trading Symbol Trading Symbol Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Entity Ex Transition Period Entity Ex Transition Period Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number City Area Code City Area Code Pre Commencement Tender Offer Pre-commencement Tender Offer Cover [Abstract] Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity File Number Securities Act File Number Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Security 12b Title Title of 12(b) Security Document Type Document Type XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
Jun. 06, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001770121
Document Type 8-K
Document Period End Date Jun. 06, 2024
Entity Registrant Name SANA BIOTECHNOLOGY, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39941
Entity Tax Identification Number 83-1381173
Entity Address, Address Line One 188 East Blaine Street
Entity Address, Address Line Two Suite 400
Entity Address, City or Town Seattle
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98102
City Area Code (206)
Local Phone Number 701-7914
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol SANA
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports sana-20240606.htm sana-20240606.xsd http://xbrl.sec.gov/dei/2023 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "sana-20240606.htm": { "nsprefix": "sana", "nsuri": "http://sana.com/20240606", "dts": { "inline": { "local": [ "sana-20240606.htm" ] }, "schema": { "local": [ "sana-20240606.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_d166a53e-da8b-4fc1-9596-6c694f60ee5e", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "sana-20240606.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d166a53e-da8b-4fc1-9596-6c694f60ee5e", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "sana-20240606.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre Commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre Commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security 12b Title", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://sana.com/20240606/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 12 0000950170-24-070603-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-070603-xbrl.zip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end XML 14 sana-20240606_htm.xml IDEA: XBRL DOCUMENT 0001770121 2024-06-06 2024-06-06 0001770121 false 8-K 2024-06-06 SANA BIOTECHNOLOGY, INC. DE 001-39941 83-1381173 188 East Blaine Street Suite 400 Seattle WA 98102 (206) 701-7914 false false false false Common Stock, $0.0001 par value per share SANA NASDAQ true false